菩鏹股份有限公司

主成分
The potency of Heparin Sodium, calculated on the dried basis, is NLT 180 USP Heparin Units in each mg. 
適應症
抗凝血劑
主成分
Mometasone Furoate contains 97.0%~102.0% of C27H30Cl2O6, calculated on the dried basis. 
適應症
腎上腺皮質類固醇
主成分
Medroxyprogesterone Acetate contains not less than 97.0% and not more than 103.0% of C24H34O4, calculated on the dried basis. 
適應症
女性內分泌藥
主成分
Betamethasone contains not less than 97.0% and not more than 103.0% of C22H29FO5, calculated on the dried basis. 
適應症
醣類代謝皮質素
主成分
Betamethasone (Betamethasone contains not less than 97.0 percent and not more than 103.0 percent of C22H29FO5, calculated on the dried basis.) 
適應症
醣類代謝皮質素
主成分
Progesterone contains not less than 97.0% and not more than 103.0% of C21H30O2, calculated on the dried basis. 
適應症
內分泌素
主成分
Methylprednisolone 11β,17,21-Trihydroxy-6 α -methylpregna-1,4-diene-3,20-dione. Content:97.0% to 103.0%(dried substance). 
適應症
抗炎性皮質固醇
主成分
Fluticasone Propionate contains not less than 98.0% and not more than 101.0% of C25H31F3O5S Calculated on the dried basis.  
適應症
抗炎性皮質固醇(外用)
主成分
PREDNISOLONE 
適應症
抗炎性皮質固醇。
主成分
Ethinylestradiol contains not less than 97.0% and not more than 102.0% of C20H24O2, calculated on the dried basis. 
適應症
女性荷爾蒙劑
主成分
Hydrocortisone contains NLT 97.0% and NMT 102.0% of C21H30O5, calculated on the dried basis. 
適應症
抗炎性皮質固醇
主成分
Dexamethasone contains NLT 97.0% and NMT 102.0% of C22H29FO5, calculated on the dried basis. 
適應症
抗炎性皮質固醇
主成分
HYDROCORTISONE 
適應症
抗炎性皮質醇。
主成分
PREDNISOLONE ACETATE 
適應症
抗炎性皮質固醇。
主成分
Estradiol Valerate contains not less than 98.0% and not more than 102.0% of C23H32O3. 
適應症
卵胞荷爾蒙劑
主成分
Norethisterone contains not less than 97.0% and not more than 102.0% of C20H26O2, calculated on the dried basis. 
適應症
黃體荷爾蒙劑
主成分
Megestrol Acetate 97.0% to 102.0% (dried substance). 
適應症
女性內分泌藥
主成分
Hydrocortisone Acetate contains not less than 97.0% and not more than 102.0% of C23H32O6, calculated on the dried basis. 
適應症
腎上腺皮質固醇。
主成分
Hydrocortisone Acetate contains NLT 97.0% and NMT 102.0% of C23H32O6, calculated on the dried basis. 
適應症
腎上腺皮質固醇
主成分
Prednisolone contains not less than 96.5% and not more than 102.0% of C21H28O5, calculated on the dried substance. 
適應症
抗炎性皮質固醇
主成分
Dexamethasone Sodium Phosphate contains NLT 97.0% and NML 102.0% of dexamethasone sodium phosphate (C22H28FNa2O8P), calculated on the anhydrous and solvent-free basis. 
適應症
醣類代謝皮質素
主成分
Spironolactone contains not less than 97.0 percent and not more than 103.0 percent of C24H32O4S, calculated on the dried basis. 
適應症
利尿劑
主成分
HYDROCORTISONE ACETATE CONTAINS NOT LESS THAN 97% AND NOT MORE THAN 102% OF C23H32O6, CALCULATED ON THE DRIED BASIS. 
適應症
腎上腺皮質固醇。
主成分
Hydrocortisone contains not less than 97% and not more than 102% of C21H30O5,calculated on the dried basis 
適應症
抗炎性皮質固醇
主成分
Dexamthasone Sodium Phosphate contains not less than 97.0 percent and not more than 102.0 percent of C22H28FNa2O8P, calculated on the water-free and alcohol-free basis. 
適應症
醣類代謝皮質素。
主成分
Dexamethasone contains not less than 97.0% and not more than 102.0% of C22H29FO5, calculated on the dried basis. 
適應症
抗炎性皮質固醇。
主成分
Betamethasone Sodium Phosphate contains not less than 96.0 % and not more than 103.0 % of C22H28FNa2O8P,calculated on the dried basis. 
適應症
抗炎性皮質固醇。
主成分
Clobetasol Propionate contains not less than 97.0% and not more than 102.0% of C25H32ClFO5, calculated on the dried basis. 
適應症
抗炎性皮質固醇。
主成分
Betamethasone Valerate contains not less than 97.0 % and not more than 103.0 % of C27H37FO6,calculated on the dried basis. 
適應症
抗炎性皮質醇(外用)。
主成分
Triamcinolone Acetonide contains not less than 97.0 % and not more than 102.0 % of C24H31FO6 ,calculated on the dried basis. 
適應症
抗炎性皮質固醇藥。
主成分
Betamethasone Dipropionate contains not less than 97.0%and not more than 103.0% of C28H37FO7,calculated on the dried basis. 
適應症
副腎皮質荷爾蒙。
主成分
Neomycin Sulfate has a potency equivalent to not less than 600 µg of neomycin per mg, calculated on the dried basis. 
適應症
抗生素
主成分
Prednisolone Sodium Phosphate contains not less than 96.0% to 103.0% of C21H27Na2O8P calculated on the dried basis. 
適應症
消炎劑
主成分
Clindamycin Phosphate (Clindamycin Phosphate has a potency equivalent to not less than 758 μg/mg of clindamycin (C18H33ClN2O5S), calculated on the anhydrous basis.) 
適應症
抗生素